Merck (MSD)

Merck & Co., Inc. (Rahway, NJ; trades as MSD outside the US and Canada) is one of the world's largest research-intensive biopharmaceutical companies, with roughly $60B+ annual revenue and a workforce in the tens of thousands across human health, vaccines, and animal health. Its portfolio is anchored by the cancer immunotherapy Keytruda (a glass-vial/biologic product) and the HPV vaccine Gardasil (a prefilled-syringe product), alongside a growing pipeline of biologics, antibody-drug conjugates, and combination/device products such as next-generation inhalers. The company is executing a multi-billion-dollar US manufacturing buildout (Durham NC vaccines, Wilmington DE biologics/ADCs, a Virginia site) and operates aseptic fill-finish and device-packaging lines globally. This profile is built from public sources; note Merck & Co. (merck.com) is legally distinct from Germany's Merck KGaA / MilliporeSigma, whose robotics activity is NOT attributed here.